"Chen Yu, has the new drug you mentioned still not been approved?" After the seminar, Professor Zhang and his wife, together with Chen Yu, left the meeting room. As they walked towards Chen Yu's office, Professor Zhang asked with concern.
"Didn't I already explain this to you, Professor?" Chen Yu felt somewhat helpless but still explained, "The development of the broad-spectrum anti-cancer drug is complete, and the animal testing went very smoothly. What's underway now is the human clinical trial.
The case of Wang Jiancheng exists as a collaborative treatment project between Tokyo University Medical School Hospital and the university. Its purpose is to verify the efficacy and drug reactions of this broad-spectrum anti-cancer drug among different ethnic groups in different countries.
